{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:02:46Z","timestamp":1773979366809,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.vaccine.2023.11.023","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T04:17:46Z","timestamp":1700885866000},"page":"7618-7625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Variable long-term protection by radiation-, chemo-, and genetically-attenuated Plasmodium berghei sporozoite vaccines"],"prefix":"10.1016","volume":"41","author":[{"given":"Diana","family":"Moita","sequence":"first","affiliation":[]},{"given":"Helena","family":"Nunes-Caba\u00e7o","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"R\u00f4la","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6041-4182","authenticated-orcid":false,"given":"Blandine","family":"Franke-Fayard","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6410-6205","authenticated-orcid":false,"given":"Chris J.","family":"Janse","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6562-5325","authenticated-orcid":false,"given":"Ant\u00f3nio M.","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Prud\u00eancio","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2023.11.023_b0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ni.f.205","article-title":"Immunity to malaria: more questions than answers","volume":"9","author":"Langhorne","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2023.11.023_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.01617","article-title":"Immune escape strategies of malaria parasites","volume":"7","author":"Gomes","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2023.11.023_b0015","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6529681","article-title":"Immune response and evasion mechanisms of Plasmodium falciparum parasites","volume":"2018","author":"Belachew","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2023.11.023_b0020","article-title":"Host-parasite interactions during Plasmodium infection: implications for immunotherapies","volume":"13","author":"Chandley","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2023.11.023_b0025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrmicro1529","article-title":"The silent path to thousands of merozoites: the Plasmodium liver stage","volume":"4","author":"Prudencio","year":"2006","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.023_b0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm.3073","article-title":"Malaria biology and disease pathogenesis: insights for new treatments","volume":"19","author":"Miller","year":"2013","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.023_b0035","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4269\/ajtmh.17-0895","article-title":"Understanding the liver-stage biology of malaria parasites: insights to enable and accelerate the development of a highly efficacious vaccine","volume":"99","author":"Mo","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.11.023_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.977472","article-title":"Five decades of clinical assessment of whole-sporozoite malaria vaccines","volume":"13","author":"Nunes-Cabaco","year":"2022","journal-title":"Front Immunol"},{"issue":"6152","key":"10.1016\/j.vaccine.2023.11.023_b0045","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"},{"issue":"544","key":"10.1016\/j.vaccine.2023.11.023_b0050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz5629","article-title":"A double-blind, placebo-controlled phase 1\/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1","volume":"12","author":"Roestenberg","year":"2020","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.023_b0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-022-00558-x","article-title":"Creation and preclinical evaluation of genetically attenuated malaria parasites arresting growth late in the liver","volume":"7","author":"Franke-Fayard","year":"2022","journal-title":"npj Vaccines"},{"issue":"7642","key":"10.1016\/j.vaccine.2023.11.023_b0060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature21060","article-title":"Sterile protection against human malaria by chemoattenuated PfSPZ vaccine","volume":"542","author":"Mordmuller","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.11.023_b0065","unstructured":"Franke-Fayard B. Development and clinical evaluation of genetically attenuated parasite that arrests late in the liver. In: Oral presentation Tues, Nov 1, 10:45 am, 2022 annual meeting of the American Society for Tropical Medicine and Hygiene; 2022."},{"issue":"9779","key":"10.1016\/j.vaccine.2023.11.023_b0070","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0140-6736(11)60360-7","article-title":"Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study","volume":"377","author":"Roestenberg","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.023_b0075","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nm.4110","article-title":"Protection against malaria at 1 year and immune correlates following PfSPZ vaccination","volume":"22","author":"Ishizuka","year":"2016","journal-title":"Nat Med"},{"issue":"9988","key":"10.1016\/j.vaccine.2023.11.023_b0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"Rts","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.11.023_b0085","doi-asserted-by":"crossref","unstructured":"Doolan DL, Dobano C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev 2009;22(1):13\u201336, Table of Contents.","DOI":"10.1128\/CMR.00025-08"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.023_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109956","article-title":"Expeditious recruitment of circulating memory CD8 T cells to the liver facilitates control of malaria","volume":"37","author":"Lefebvre","year":"2021","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.023_b0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/imr.13202","article-title":"Memory CD8+ T cell-mediated protection against liver-stage malaria","volume":"316","author":"Hassert","year":"2023","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.023_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031247","article-title":"Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites","volume":"7","author":"Weiss","year":"2012","journal-title":"PLoS One"},{"issue":"6055","key":"10.1016\/j.vaccine.2023.11.023_b0105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.1211548","article-title":"Live attenuated malaria vaccine designed to protect through hepatic CD8(+) T cell immunity","volume":"334","author":"Epstein","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.023_b0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2567.2010.03363.x","article-title":"Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii","volume":"132","author":"Chandele","year":"2011","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.023_b0115","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.celrep.2013.11.002","article-title":"PD-1 dependent exhaustion of CD8+ T cells drives chronic malaria","volume":"5","author":"Horne-Debets","year":"2013","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.023_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002504","article-title":"The CTLA-4 and PD-1\/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology","volume":"8","author":"Hafalla","year":"2012","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.023_b0125","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4049\/jimmunol.1202438","article-title":"Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion","volume":"190","author":"Illingworth","year":"2013","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.023_b0130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ni.2180","article-title":"Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection","volume":"13","author":"Butler","year":"2011","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.023_b0135","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2023.11.023_b0140","doi-asserted-by":"crossref","DOI":"10.1038\/srep26210","article-title":"Mice lacking Programmed cell death-1 show a role for CD8(+) T cells in long-term immunity against blood-stage malaria","volume":"6","author":"Horne-Debets","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2023.11.023_b0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2875-13-15","article-title":"Simple, sensitive and quantitative bioluminescence assay for determination of malaria pre-patent period","volume":"13","author":"Zuzarte-Luis","year":"2014","journal-title":"Malar J"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.023_b0150","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.4049\/jimmunol.171.4.2024","article-title":"Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells","volume":"171","author":"Berenzon","year":"2003","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2023.11.023_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000998","article-title":"Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites","volume":"6","author":"Schmidt","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2023.11.023_b0160","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.023_b0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s40425-019-0814-7","article-title":"PD1(Hi) CD8(+) T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma","volume":"7","author":"Ma","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"22","key":"10.1016\/j.vaccine.2023.11.023_b0170","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1158\/0008-5472.CAN-16-3167","article-title":"PD-1 status in CD8(+) T cells associates with survival and anti-PD-1 therapeutic outcomes in head and neck cancer","volume":"77","author":"Kansy","year":"2017","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.023_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11819-0","article-title":"Innate immunity limits protective adaptive immune responses against pre-erythrocytic malaria parasites","volume":"10","author":"Minkah","year":"2019","journal-title":"Nat Commun"},{"issue":"5111","key":"10.1016\/j.vaccine.2023.11.023_b0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/216160a0","article-title":"Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei","volume":"216","author":"Nussenzweig","year":"1967","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.023_b0185","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2016.08.011","article-title":"Liver-resident memory CD8(+) T cells form a front-line defense against malaria liver-stage infection","volume":"45","author":"Fernandez-Ruiz","year":"2016","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.vaccine.2023.11.023_b0190","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.4049\/jimmunol.1800740","article-title":"Prime-and-trap malaria vaccination to generate protective CD8(+) liver-resident memory T cells","volume":"201","author":"Olsen","year":"2018","journal-title":"J Immunol"},{"issue":"48","key":"10.1016\/j.vaccine.2023.11.023_b0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaz8035","article-title":"Glycolipid-peptide vaccination induces liver-resident memory CD8(+) T cells that protect against rodent malaria","volume":"5","author":"Holz","year":"2020","journal-title":"Sci Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.023_b0200","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.chom.2020.04.010","article-title":"A natural peptide antigen within the plasmodium ribosomal protein RPL6 confers liver T(RM) cell-mediated immunity against malaria in mice","volume":"27","author":"Valencia-Hernandez","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.023_b0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41541-021-00360-1","article-title":"Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection","volume":"6","author":"Sahu","year":"2021","journal-title":"npj Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.023_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036508","article-title":"Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNgamma responses of hepatic CD8+ memory T cells","volume":"7","author":"Nganou-Makamdop","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.023_b0215","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/339409","article-title":"Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites","volume":"185","author":"Hoffman","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.023_b0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.20021072","article-title":"Malaria blood stage suppression of liver stage immunity by dendritic cells","volume":"197","author":"Ocana-Morgner","year":"2003","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.023_b0225","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89154","article-title":"Protection against Plasmodium falciparum malaria by PfSPZ Vaccine","volume":"2","author":"Epstein","year":"2017","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.023_b0230","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4269\/ajtmh.1991.45.539","article-title":"Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals","volume":"45","author":"Herrington","year":"1991","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.023_b0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000441-197309000-00002","article-title":"Immunization of man against sporozite-induced falciparum malaria","volume":"266","author":"Clyde","year":"1973","journal-title":"Am J Med Sci"},{"issue":"659","key":"10.1016\/j.vaccine.2023.11.023_b0240","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn9709","article-title":"A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection","volume":"14","author":"Murphy","year":"2022","journal-title":"Sci Transl Med"},{"issue":"13","key":"10.1016\/j.vaccine.2023.11.023_b0245","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135589","article-title":"A replication-competent late liver stage-attenuated human malaria parasite","volume":"5","author":"Goswami","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2023.11.023_b0250","series-title":"Oral presentation Tues, Nov 1, 2022 Annual meeting of the American Society for Tropical Medicine and Hygiene","article-title":"Generation and clinical development of a Plasmodium falciparum genetically attenuated parasite vaccine with complete late liver stage arrest (PfSPZ-LARC2)","author":"Goswami","year":"2022"},{"key":"10.1016\/j.vaccine.2023.11.023_b0255","series-title":"Oral presentation Tues, Nov 1, 2022 annual meeting of the American Society for Tropical Medicine and Hygiene","article-title":"PfSPZ-LARC2 GMP manufacture and clinical assessment of a genetically modified PfSPZ vaccine attenuated at the late-liver stage","author":"Sim","year":"2022"},{"issue":"32","key":"10.1016\/j.vaccine.2023.11.023_b0260","doi-asserted-by":"crossref","first-page":"11468","DOI":"10.1073\/pnas.0503386102","article-title":"Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration","volume":"102","author":"Franke-Fayard","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2023.11.023_b0265","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03582","article-title":"A genetically attenuated malaria vaccine candidate based on P. falciparum b9\/slarp gene-deficient sporozoites","volume":"3","author":"van Schaijk","year":"2014","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.023_b0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","article-title":"User's guide to correlation coefficients","volume":"18","author":"Akoglu","year":"2018","journal-title":"Turk J Emerg Med"},{"key":"10.1016\/j.vaccine.2023.11.023_bib271","doi-asserted-by":"crossref","unstructured":"Moita D. et al. The effect of dosage on the protective efficacy of whole-sporozoite formulations for immunization against malaria. NPJ Vaccines, https:\/\/doi.org\/10.1038\/s41541-023-00778-9.","DOI":"10.1038\/s41541-023-00778-9"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2301335X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2301335X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:32:19Z","timestamp":1759404739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2301335X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":55,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0264410X2301335X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variable long-term protection by radiation-, chemo-, and genetically-attenuated Plasmodium berghei sporozoite vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}